Wiley Bros. Aintree Capital, LLC Prime Medicine, Inc. Transaction History
Wiley Bros. Aintree Capital, LLC
- $14.9 Billion
- Q3 2025
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 11,848 shares of PRME stock, worth $39,927. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,848Holding current value
$39,927% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PRME
# of Institutions
178Shares Held
89MCall Options Held
1.32MPut Options Held
931K-
Alphabet Inc. Mountain View, CA16.6MShares$55.8 Million5.44% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.22MShares$31.1 Million0.03% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.48MShares$18.5 Million0.21% of portfolio
-
Black Rock Inc. New York, NY5.11MShares$17.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.92MShares$16.6 Million0.0% of portfolio
About Prime Medicine, Inc.
- Ticker PRME
- Shares Outstandng 95,730,200
- Market Cap $323M